Exploratory Study on mRNA Therapeutic Drug Targeting CD19 for the Treatment of Hematologic Malignancies

Clinical trial NCT07349849 · RECRUITING

Trial details

NCT number: NCT07349849
Sponsor: Xinqiao Hospital of Chongqing
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

B-cell Malignancies

Start date: 2025-12-20
Primary completion: 2028-01-01
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.